Results 81 to 90 of about 9,912 (208)

Evidence to support the use of vildagliptin monotherapy in the treatment of type 2 diabetes mellitus

Vascular Health and Risk Management, 2012
Sylvie Dejager,1 Anja Schweizer,2 James E Foley31Novartis Pharma SAS, Rueil Malmaison, France; 2Novartis Pharma AG, Basel, Switzerland; 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAAbstract: The efficacy and safety of the dipeptidyl ...
Dejager S, Schweizer A, Foley JE
doaj  

Pharmacoeconomic analysis of type 2 diabetes mellitus by vildagliptin medication in Kazakhstan [PDF]

, 2014
This study is aimed to determine cost-effectiveness of vildagliptin in comparison with sitagliptin for the treatment of patients with type 2 diabetes mellitus (T2DM) from the perspective of Ministry of Health of the Republic of ...
Bektur, C., Nurgozhin, T., Yelekenova, A.   +2 more
core  

CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation† [PDF]

, 2017
OBJECTIVES The CD26 antigen is a transmembrane glycoprotein that is constitutively expressed on activated lymphocytes and in pulmonary parenchyma. This molecule is also identified as dipeptidyl peptidase-4 (DPP-4) that cleaves a host of biologically ...
Arni, Stephan, Baerts, Lesley, De Meester, Ingrid, Jungraithmayr, Wolfgang, Matheeussen, Veerle, Weder, Walter   +5 more
core  

Study protocol for a cluster-randomized controlled trial of an NCD access to medicines initative: Evaluation of Novartis Access in Kenya [PDF]

, 2016
INTRODUCTION: Novartis recently launched Novartis Access, an initiative to provide a basket of reduced price medicines for non-communicable diseases (NCDs) to be sold through the public and private nonprofit sectors in programme countries.
Ashigbie, Paul G., Laing, Richard, Onyango, Monica A., Rockers, Peter C., Vian, Taryn, Wirtz, Veronika J.   +5 more
core   +1 more source

Myocardial-salvaging Effects of a Novel Polyherbal Combination with Dipeptidyl Peptidase-4 Inhibitory Activity

Nigerian Postgraduate Medical Journal
Background: Some of the medicinal plants possess dipeptidyl peptidase-4 (DPP-4) inhibitory properties and could overcome the limitations of synthetic DPP-4 inhibitors.
Devkumar Durgaprasad Tiwari, Ipseeta Ray Mohanty, Ujwala Maheswari, Prithviraj M. Erande, Vandana M Thorat, Aneesa B. Sayed   +5 more
doaj   +1 more source

EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus

Сахарный диабет, 2013
According to international consensus, metformin is acknowledged as a first-line therapeutic agent for type 2 diabetes mellitus (T2DM). However, in most cases this treatment eventually requires intensification by supplementation with other hypoglycemic ...
Gagik Radikovich Galstyan
doaj   +1 more source

Diabeedi ravi ja kardiovaskulaarne risk [PDF]

, 2016
Eesti Arst 2016; 95(10):667 ...
Roosimaa, Mart
core   +2 more sources

Doentes com diagnóstico prévio de diabetes perdem menos peso após banda gástrica [PDF]

, 2010
[Resumo ...
Alves, Joaquim, Belo, Sandra, Carvalho, Davide, Correia, Flora, Esteves, Cesar, Freitas, Paula, Matos, Maria, Mesquita, Joana, Nogueira, Claudia, Queirós, Joana, Rodrigues, Pedro, Santos, Ana, Varela, Ana   +12 more
core  

Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptin

Diabetes, Metabolic Syndrome and Obesity, 2013
Eleonora Russo, Giuseppe Penno, Stefano Del Prato Department of Clinical and Experimental Medicine, Section of Diabetes and Metabolic Disease, Azienda Ospedaliero Universitaria di Pisa, and University of Pisa, Pisa, Italy Background: Dipeptidyl peptidase-
Russo E, Penno G, Del Prato S
doaj  

Mild acute pancreatitis with vildagliptin use

Indian Journal of Endocrinology and Metabolism, 2012
Vildagliptin has not been associated with the development of acute pancreatitis in postmarketing reports except one case report from Sydney, Australia.
Ravikant Saraogi, Ritwika Mallik, Sujoy Ghosh   +2 more
doaj   +1 more source